Almost four years ago to the date, Sebastian Martinez was diagnosed with stage four terminal cancer and told he had 14 months to live.

Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several independent cohorts in a pooled ...